Using Dendritic Cell-Based Immunotherapy to Treat HIV: How Can This Strategy be Improved?

Harnessing dendritic cells (DC) to treat HIV infection is considered a key strategy to improve anti-HIV treatment and promote the discovery of functional or sterilizing cures. Although this strategy represents a promising approach, the results of currently published trials suggest that opportunities...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silva, Laís Teodoro, Santillo, Bruna Tereso, de Almeida, Alexandre, Duarte, Alberto Jose da Silva, Oshiro, Telma Miyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305438/
https://www.ncbi.nlm.nih.gov/pubmed/30619346
http://dx.doi.org/10.3389/fimmu.2018.02993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305438/
https://www.ncbi.nlm.nih.gov/pubmed/30619346
http://dx.doi.org/10.3389/fimmu.2018.02993

Ejemplares similares